Article: How MFN clauses used in the health care industry unreasonably restrain trade under the Sherman Act.(most favored nations)

 
 INTRODUCTION 
  I. THE SHERMAN ACT 
 II. THE BALANCING TEST UNDER THE RULE OF REASON 
 A. Quadrant I: Pro-competitive Purposes 
1. Guard Against Discriminatory Pricing 
2. Tool to Secure Volume Discounts 
 B. Quadrant III: Pro-competitive Effects 
1. Lower Prices Overall 
2. Guarantee the Same Best Price 
 C. Quadrant II: Anticompetitive Purposes 
1. Creating an Artificial Price Floor 
2. Price Certainty 
 D. Quadrant IV: Anticompetitive Effects 
1. Horizontal Price-fixing 
2. Unreasonably Restrains Vertical Trade 
3. Elimination of Price Discrimination 
4. Preempts a Genuine Market ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!